North Star Investment Management Corp. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2023$72
-18.2%
1250.0%0.00%
Q1 2023$88
-68.8%
1250.0%0.00%
Q4 2022$2821250.0%0.00%
Q3 2022$01250.0%0.00%
Q2 2022$0
-100.0%
1250.0%0.00%
Q1 2022$1,000
-50.0%
1250.0%0.00%
Q4 2021$2,0000.0%1250.0%0.00%
Q3 2021$2,0000.0%1250.0%0.00%
Q2 2021$2,0000.0%1250.0%0.00%
Q1 2021$2,0000.0%1250.0%0.00%
Q4 2020$2,0000.0%1250.0%0.00%
Q3 2020$2,000
-33.3%
1250.0%0.00%
Q2 2020$3,000
+50.0%
1250.0%0.00%
Q1 2020$2,000
-33.3%
1250.0%0.00%
Q4 2019$3,000
+50.0%
1250.0%0.00%
Q3 2019$2,000
-33.3%
125
+66.7%
0.00%
Q1 2019$3,000
+50.0%
750.0%0.00%
Q4 2018$2,000
-33.3%
75
+50.0%
0.00%
Q3 2018$3,000500.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders